| Referral patterns of uveitis in a tertiary eye care center A Rodriguez, M Calonge, M Pedroza-Seres, YA Akova, EM Messmer, ... Archives of ophthalmology 114 (5), 593-599, 1996 | 556 | 1996 |
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting C Baudouin, P Aragona, EM Messmer, A Tomlinson, M Calonge, ... The ocular surface 11 (4), 246-258, 2013 | 515 | 2013 |
| Applications of nanoparticles in ophthalmology Y Diebold, M Calonge Progress in retinal and eye research 29 (6), 596-609, 2010 | 438 | 2010 |
| Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease A Enríquez-de-Salamanca, E Castellanos, ME Stern, I Fernández, ... Molecular vision 16, 862, 2010 | 427 | 2010 |
| Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance AE de Salamanca, Y Diebold, M Calonge, C García-Vazquez, S Callejo, ... Investigative ophthalmology & visual science 47 (4), 1416-1425, 2006 | 368 | 2006 |
| Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP) Y Diebold, M Jarrín, V Sáez, ELS Carvalho, M Orea, M Calonge, B Seijo, ... Biomaterials 28 (8), 1553-1564, 2007 | 345 | 2007 |
| The treatment of dry eye M Calonge Survey of ophthalmology 45, S227-S239, 2001 | 342 | 2001 |
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) AJ Bron, MB Abelson, G Ousler, E Pearce, A Tomlinson, N Yokoi, ... Ocular Surface 5 (2), 108-152, 2007 | 340 | 2007 |
| Ocular surface alteration after long-term treatment with an antiglaucomatous drug JM Herreras, JC Pastor, M Calonge, VM Asensio Ophthalmology 99 (7), 1082-1088, 1992 | 328 | 1992 |
| Atopic keratoconjunctivitis CS Foster, M Calonge Ophthalmology 97 (8), 992-1000, 1990 | 283 | 1990 |
| Impression cytology of the ocular surface: a review M Calonge, Y Diebold, V Sáez, AE de Salamanca, C Garcı́a-Vázquez, ... Experimental eye research 78 (3), 457-472, 2004 | 251 | 2004 |
| Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva Y Diebold, M Calonge, AE de Salamanca, S Callejo, RM Corrales, V Sáez, ... Investigative ophthalmology & visual science 44 (10), 4263-4274, 2003 | 196 | 2003 |
| Role of corneal nerves in ocular surface homeostasis and disease M Labetoulle, C Baudouin, M Calonge, J Merayo‐Lloves, KG Boboridis, ... Acta ophthalmologica 97 (2), 137-145, 2019 | 181 | 2019 |
| Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A P Calvo, A Sánchez, J Martínez, MI López, M Calonge, JC Pastor, ... Pharmaceutical research 13, 311-315, 1996 | 173 | 1996 |
| Autoimmunity at the ocular surface: pathogenesis and regulation ME Stern, CS Schaumburg, R Dana, M Calonge, JY Niederkorn, ... Mucosal immunology 3 (5), 425-442, 2010 | 157 | 2010 |
| Epidermal growth factor and corneal wound healing: a multicenter study JC Pastor, M Calonge Cornea 11 (4), 311-314, 1992 | 152 | 1992 |
| Dry eye disease as an inflammatory disorder M Calonge, A Enríquez-de-Salamanca, Y Diebold, MJ González-García, ... Ocular immunology and inflammation 18 (4), 244-253, 2010 | 133 | 2010 |
| Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions A López-Miguel, M Tesón, V Martín-Montañez, A Enríquez-de-Salamanca, ... American Journal of Ophthalmology 157 (4), 788-798. e2, 2014 | 132 | 2014 |
| Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves. T Girbes, L Citores, R Iglesias, JM Ferreras, R Munoz, MA Rojo, FJ Arias, ... Journal of Biological Chemistry 268 (24), 18195-18199, 1993 | 131 | 1993 |
| Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells L Contreras-Ruiz, M de la Fuente, JE Párraga, A López-García, ... Molecular vision 17, 279, 2011 | 130 | 2011 |
Amalia Enríquez de SalamancaPrincipal Investigator Ocular Surface Group-IOBA (Instituto Oftalmobiología Aplicada)-UVa; CIBER-BBNVerified email at ioba.med.uva.es
